市場調查報告書
商品編碼
1561454
2024-2032 年按產品、應用、最終用戶和地區分類的 3D 細胞培養市場報告3D Cell Culture Market Report by Product, Application, End User, and Region 2024-2032 |
2023年,全球3D細胞培養市場規模達23.232IMARC Group美元。對用於診斷癌症的3D 組織工程模型的需求不斷成長,對氣道和氣液界面類器官的需求不斷成長,以及需要體內模型系統的研究中的利用率不斷提高,這些都是推動市場發展的一些關鍵因素。
3D 細胞培養是一種培養環境,使細胞能夠在三個維度上生長並與周圍的細胞外框架相互作用。它與傳統的 2D 細胞培養形成鮮明對比,傳統的 2D 細胞培養中細胞在平板上的平坦單層中生長。它可以在支撐支架(例如水凝膠和惰性基質)中培養,以允許在各個方向上生長。它依賴於無支架方法,例如低黏附板、微圖案表面和懸滴,使細胞能夠自組裝成簇或球體。它是在微晶片的室內進行的,微晶片允許液體流動,在整個細胞中運輸和分配營養物質或其他化學物質。與2D細胞培養相比,它更準確地代表細胞駐留在組織中的實際微環境。由於 3D 培養的額外維度更能反映體內細胞反應,因此全球對 3D 細胞培養的需求正在上升。
目前,在需要體內模型系統的研究中擴大使用3D細胞培養,因為3D培養可以密切模仿器官的典型形態和微結構,這是支持市場成長的關鍵因素之一。除此之外,世界各地也擴大使用 3D 組織工程模型來診斷癌症和其他臨床疾病。再加上對 3D 細胞培養分析外國藥物對身體組織和器官影響的需求不斷成長,提供了良好的市場前景。此外,與 2D 技術相比,3D 細胞培養是一種簡單且廉價的體外腫瘤宿主環境,因此對 3D 細胞培養的需求不斷成長,正在推動市場的成長。此外,擴大使用 3D 模型進行呼吸系統疾病研究,為行業投資者提供了利潤豐厚的成長機會。除此之外,對氣道和氣液界面類器官的需求不斷增加,以開發和發現抗病毒藥物以及作為實驗病毒學平台和研究免疫反應。再加上新產品的推出以及 3D 協定在生物研究中的廣泛應用,正在加強市場的成長。
The global 3D cell culture market size reached US$ 2,323.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,418.7 Million by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032. The growing demand for 3D tissue-engineered models to diagnose cancer, rising need for airway and air-liquid interface organoids, and increasing utilization in studies that require in vivo model systems represent some of the key factors driving the market.
3D cell culture is a culture environment that enables cells to grow and interact with surrounding extracellular frameworks in three dimensions. It is a contrast to traditional 2D cell cultures wherein cells are grown in a flat monolayer on a plate. It can be cultured within supporting scaffolds, such as hydrogels and inert matrices, to allow growth in all directions. It relies on scaffold-free methods, such as low-adhesion plates, micropatterned surfaces, and hanging drops, for allowing cells to self-assemble into clusters or spheroids. It is performed within the chambers of a microchip that allows the flow of liquid to transport and distribute nutrients or other chemicals throughout the cells. It represents more accurately the actual microenvironment wherein cells reside in tissues compared to 2D cell culture. As it is more reflective of in vivo cellular responses due to the additional dimensionality of 3D cultures, the demand for 3D cell culture is rising across the globe.
At present, the increasing utilization of 3D cell culture in studies that require in vivo model systems, as 3D cultures can closely mimic a typical morphology and microarchitecture of organs, represents one of the key factors supporting the growth of the market. Besides this, there is a rise in the employment of 3D tissue-engineered models to diagnose cancer and other clinical disorders among the masses around the world. This, along with the growing demand for 3D cell culture to analyze the effects of a foreign drug over body tissues and organs, is offering a favorable market outlook. In addition, the rising demand for 3D cell culture, as it is a simple and inexpensive in vitro tumor-host environment compared to 2D techniques, is propelling the growth of the market. Moreover, the increasing usage of 3D models for performing research about respiratory diseases is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for airway and air-liquid interface organoids to develop and discover antiviral drugs and as experimental virology platforms and study the immune responses. This, coupled with the launch of new products and wide applications of 3D protocols in biological research, is strengthening the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D cell culture market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
The report has provided a detailed breakup and analysis of the 3D cell culture market based on the product. This includes scaffold-based platforms, scaffold-free platforms, microchips, bioreactors, and others. According to the report, scaffold-based platforms represented the largest segment.
A detailed breakup and analysis of the 3D cell culture market based on the application has also been provided in the report. This includes cancer research, stem cell research, drug discovery, regenerative medicine, and others. According to the report, cancer research accounted for the largest market share.
A detailed breakup and analysis of the 3D cell culture market based on the end user has also been provided in the report. This includes biotechnology and pharmaceutical companies, contract research laboratories, academic institutes, and others. According to the report, biotechnology and pharmaceutical companies accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D cell culture. Some of the factors driving the North America 3D cell culture market included the government funding for the development of advanced 3D cell culture models, high healthcare spending, the presence of a large number of universities and research organizations, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global 3D cell culture market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include 3D Biotek LLC, Advanced Biomatrix Inc., Avantor Inc., CN Bio Innovations Limited, Corning Incorporated, Emulate Inc., InSphero AG, Lonza Group AG, Merck KGaA, Promocell GmbH, Synthecon Inc, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.